
Designed by UK podiatrists
Targeted pressure relief for corns and callus, in everyday shoes.
ZeroSole's silicone hexagon cells pull out by hand beneath the painful area, creating a custom offloading zone in seconds. Used across the NHS.

Why Kaydiar Medical
What sets Kaydiar Medical apart
Up to 32% less pressure
At the target area, without affecting gait (ATiC pressure mapping).
Clinically proven
Significant pain reduction over six weeks in a Cardiff Met study.
Modify in seconds
No scissors or equipment: perfect for busy clinics and home visits.
Fits everyday shoes
A low-profile insole with arch support and heel cup.
The range
Kaydiar Medical products
Kaydiar Medical is a UK company founded by podiatrists David Barton and Heather Smart. Its ZeroSole Reliever is a customisable offloading insole for corns, calluses, metatarsalgia, heel pain and other pressure-induced foot pain. ZeroSole is supplied through the NHS and professional podiatry wholesalers.
How ZeroSole works
ZeroSole has a grid of medical-grade silicone hexagon cells over a memory-foam mid-layer. To create a pressure-relief zone, you simply pull out the cells directly beneath the painful area, with no scissors or special equipment. This takes load away from the lesion, while the rest of the insole keeps cushioning the foot. It takes seconds to modify, so it is ideal for busy clinics and home visits.
- Targeted offloading: removing cells reduces pressure at the target area by up to 32% compared with normal shoes
- Full-length cushioning with a mild arch support and heel cup
- Low profile: fits into everyday footwear, which helps patients keep wearing it
- Durable: an integral silicone design that lasts at least 6 months
- Two sizes: UK 4–7 (EU 37–41) and UK 8–11 (EU 42–46), with UK/EU/US trim lines printed on the insole
How to fit ZeroSole
The evidence
- Laboratory pressure mapping (Assistive Technologies Innovation Centre, University of Wales Trinity Saint David, 2022): in 15 participants, ZeroSole with cells removed reduced mean pressure in the target zone by 23–32% compared with normal shoes, without affecting gait.
- Clinical study (Cardiff Metropolitan University): over six weeks, patients with plantar corns and calluses had a statistically significant reduction in pain and a clinically noteworthy reduction in lesion size.
Patients with diabetic peripheral neuropathy should use ZeroSole only under the guidance of a healthcare professional.
Downloads
- ZeroSole Reliever Brochure (PDF)
- ZeroSole Professional FAQs (PDF)
- Kaydiar Technical Features: ZeroSole & DiaSole (PDF)
- ZeroSole Clinic Poster (PDF)
- Pressure Evaluation Report, ATiC 2022 (PDF)
- Research Poster, UWTSD (PDF, 19 MB)
Want ZeroSole for your clinic or pharmacy? Contact the Qaadir team.
Supplied and supported by Qaadir
Talk to us about Kaydiar Medical
Get a quote, arrange a demo or ask about installation, training and equipment financing.